Stimulation of fracture healing by local application of humoral factors integrated in biodegradable implants

European Journal of Pediatric Surgery

Volumn 8, Issue 4, 1998, Pages 251-255

  Illi, O E ^a,c   Feldmann, C P ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Patentanwaltsbüro Feldmann AG   (Switzerland)

^c Swiss Children's Hospital   (Switzerland)

Author keywords

BMP; Drug release system; IGF 1; PDLLA implants; Stimulation of bone healing

Indexed keywords

BONE MORPHOGENETIC PROTEIN; POLYLACTIC ACID; SOMATOMEDIN C;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CATTLE; CHILD; CLINICAL ARTICLE; CRANIOPLASTY; DRUG IMPLANT; FRACTURE HEALING; HUMAN; IMPLANT; IMPLANTATION; INFANT; NONHUMAN; OSTEOSYNTHESIS; OSTEOTOMY; SWINE;

EID: 0031690512     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1071165     Document Type: Article

References (15)

1. Bak B, Jørgensen PH, Andteassen TT: Increased mechanical strength of healing rat tibial fractures treated with biosynthetic human growth hormone. Bone 11 (1990) 233-2393
2. Edwall D, Prisell PT, Levinovitz A, Jennische E, Norstedt G: Expression of insulin-like growth factor I messenger ribonucleic acid in regenerating bone after fracture: Influence of Indomethacin. J Bone Miner Res 7 (1992) 207-213
3. Hulth A: Current concepts of fracture healing. Clin Othop 249 (1989) 265-284
4. Illi OE: Biodegradable Implantate für Osteosynthesen im Kindesalter. Hans Huber Verlag, Bern, 1992
5. Illi OE, Weigum H, Misteli F: Biodegradable implant materials in fracture fixation. Clinical Materials 10 (1992) 69-73
6. Illi OE, Gitzelmann CA, Gasser B, Misteli F, Ruedi M: Five years of experience with biodegradable implants in pediatric surgery. J Mater Sci 5 (1994) 417-423
7. Kaiser A, Illi OE, Sailer HF, Stauffer UG: Cranioplasties for congenital and acquired skull defects in children - Comparison of new concepts with conventional methods. Eur J Pediatr Surg 3 (1993) 323-334
8. Perren SM: Basic aspects of internal fixation. In: Muller ME, Allgower M, Schneider R, Willenegger H. Manual of Internal Fixation, Vol 3, Springer-Verlag, Heidelberg, 1991, pp 66-72
9. Ruedi M, Rahn BA, Illi OE: Interface reactions between biodegradable implants and avascular bone grafts or vascular host site in the porcine skull. J Mater Sci 6 (1995) 181-185
10. Sailer HF, Kolb E: Purified bovine bone morphogenetic protein for clinical use in difficult conditions of cranio-maxillofacial surgery. In. Lindholm TS: Bone Morphogenetic Proteins: Biology, Biochemistry and Reconstructive Surgery, Chapter 19, Landes Bioscience, Austin, TX, USA, 1996, pp 207-230
11. Stähelin AC, Weiler A, Rüfenacht HJ, Hoffmann R, Geissmann A, Feinstein R: Clinical degradation and biocompatibility of different bioabsorbable interference screws: A report of six cases. Arthroscopy 13 (1997) 238-244
12. Tamber H, Merkle HP, Gander B: Microsphere formulation characteristics of a modified hydrophobic poly (L-Lactide) polymer Personal Communications at 3rd General Meeting of the Swiss Society of the Biomaterials, Lausanne May 6, 1997 (Abstract)
13. Teot L: La consolidation des fractures chez l'enfant. In Metaizeau JP: L'Osteosynthèse chez l'enfant, Sauramps Medical, Montpellier, 1988, pp 17-19
14. Uludag H. Biomaterial strategies for efficacious delivery of recombinant human bone morphogenic proteins. Personal Communications at 3rd General Meeting of the Swiss Society of Biomaterials, Lausanne May 6, 1997 (Abstract)
15. von Laer L: Frakturen und Luxationen im Wachstumsalter. Thieme Verlag, Stuttgart, 1991, pp 18-22